1. Cost analysis of the treatment of schizophrenia in the UK;Almond;A simulation model comparing olanzapine, risperidone and haloperidol. Pharmacoeconomics,2000
2. Costs of disorders of the brain in Europe;Eur. J. Neurology,2005
3. Economic and health state utility determinations for schizophrenic patients treated with risperidone or haloperidol;Chouinard;J. Clin. Psychopharmacol.,1997
4. Cost-effectiveness of clozapine compared with conventional antipsychotic medication for patients in state hospitals;Essock;Arch. Gen. Psychiatry,2000
5. Die direkten Kosten von depressiven Erkrankungen in Deutschland;Friemel;Ergebnisse aus dem European Study of the Epidemiology of Mental Disorders (ESEMeD) Projekt. Psychiat. Prax.,2005